Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2014, Article ID 670524, 9 pages
http://dx.doi.org/10.1155/2014/670524
Research Article

T CD3+CD8+ Lymphocytes Are More Susceptible for Apoptosis in the First Trimester of Normal Human Pregnancy

1Department of Obstetrics and Perinatology, Medical University of Lublin, Ulica Jaczewskiego 8, 20-950 Lublin, Poland
2Department of Clinical Immunology, Medical University of Lublin, 20-950 Lublin, Poland

Received 20 April 2014; Accepted 24 June 2014; Published 20 July 2014

Academic Editor: Enrico Maggi

Copyright © 2014 Dorota Darmochwal-Kolarz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. H. Wyllie, J. F. R. Kerr, and A. R. Currie, “Cell death: the significance of apoptosis,” International Review of Cytology, vol. 68, pp. 251–306, 1980. View at Publisher · View at Google Scholar · View at Scopus
  2. M. C. Raff, “Social controls on cell survival and cell death,” Nature, vol. 356, no. 6368, pp. 397–400, 1992. View at Publisher · View at Google Scholar · View at Scopus
  3. A. H. Wyllie, “Death gets a break,” Nature, vol. 369, no. 6478, pp. 272–273, 1994. View at Publisher · View at Google Scholar · View at Scopus
  4. D. W. Ross, “Apoptosis,” Archives of Pathology and Laboratory Medicine, vol. 121, pp. 83–86, 1997. View at Google Scholar
  5. D. H. Lynch, F. Ramsdell, and M. R. Alderson, “Fas and FasL in the homeostatic regulation of immune responses,” Immunology Today, vol. 16, no. 12, pp. 569–574, 1995. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Nagata and P. Golstein, “The Fas death factor,” Science, vol. 267, no. 5203, pp. 1449–1456, 1995. View at Publisher · View at Google Scholar · View at Scopus
  7. M. de Falco, R. Penta, V. Laforgia, L. Cobellis, and A. De Luca, “Apoptosis and human placenta: expression of proteins belonging to different apoptotic pathways during pregnancy,” Journal of Experimental & Clinical Cancer Research, vol. 24, no. 1, pp. 25–33, 2005. View at Google Scholar · View at Scopus
  8. Y. Yin, W. Huang, C. Lin, H. Chen, A. MacKenzie, and L. Ma, “Estrogen suppresses uterine epithelial apoptosis by inducing Birc1 expression,” Molecular Endocrinology, vol. 22, no. 1, pp. 113–125, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. U. A. Kayisli, B. Selam, O. Guzeloglu-Kayisli, R. Demir, and A. Arici, “Human chorionic gonadotropin contributes to maternal immunotolerance and endometrial apoptosis by regulating fas-fas ligand system,” Journal of Immunology, vol. 171, no. 5, pp. 2305–2313, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Kolialexi, G. T. Tsangaris, A. Antsaklis et al., “Apoptosis in maternal peripheral blood during pregnancy,” Fetal Diagnosis and Therapy, vol. 16, no. 1, pp. 32–37, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. P. von Dadelszen, R. W. G. Watson, F. Noorwali et al., “Maternal neutrophil apoptosis in normal pregnancy, preeclampsia, and normotensive intrauterine growth restriction,” American Journal of Obstetrics and Gynecology, vol. 181, no. 2, pp. 408–414, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. U. von Rango, C. A. Krusche, S. Kertschanska, J. Alfer, P. Kaufmann, and H. M. Beier, “Apoptosis of extravillous trophoblast cells limits the trophoblast invasion in uterine but not in tubal pregnancy during first trimester,” Placenta, vol. 24, no. 10, pp. 929–940, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Gleicher, A. Vidali, and V. Karande, “The immunological “wars of the roses”: disagreements amongst reproductive immunologists,” Human Reproduction, vol. 17, no. 3, pp. 539–542, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Huppertz, H.-G. Frank, J. C. P. Kingdom, F. Reister, and P. Kaufmann, “Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta,” Histochemistry and Cell Biology, vol. 110, no. 5, pp. 495–508, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. U. von Rango, “Fetal tolerance in human pregnancy—a crucial balance between acceptance and limitation of trophoblast invasion,” Immunology Letters, vol. 115, no. 1, pp. 21–32, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. C. A. Janeway, P. Travers, M. Walport, and K. J. Shlomchik, Immune Biology: The Immune System in Health and Disease, Garland Science, New York, NY, USA, 2005.
  17. F. Fallarino, U. Grohmann, K. W. Hwang et al., “Modulation of tryptophan catabolism by regulatory T cells,” Nature Immunology, vol. 4, no. 12, pp. 1206–1212, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Sabapatha, C. Gercel-taylor, and D. D. Taylor, “Specific isolation of placenta-derived exosomes from the circulation of pregnant women and their immunoregulatory consequences,” American Journal of Reproductive Immunology, vol. 56, no. 5-6, pp. 345–355, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Kvirkvelia, I. Vojnovic, T. D. Warner et al., “Placentally derived prostaglandin E2 acts via the EP4 receptor to inhibit IL-2-dependent proliferation of CTLL-2 t cells,” Clinical and Experimental Immunology, vol. 127, no. 2, pp. 263–269, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. J. L. Volumenie, B. Mogneti, D. de Smedt, E. Menu, and G. Chaouat, “Induction of transient murine T cell anergy by a low molecular weight compound obtained from supernatants of human placental cultures is linked to defective phosphorylation of TCR CD3 chain,” The American Journal of Reproductive Immunology, vol. 38, no. 3, pp. 168–175, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. F. W. Lee, J. S. Boomer, A. Gilman-sachs et al., “Regeneration and tolerance factor of the human placenta induces IL-10 production,” European Journal of Immunology, vol. 31, no. 3, pp. 687–691, 2001. View at Publisher · View at Google Scholar
  22. J. S. Boomer, G. W. Lee, T. S. Givens, A. Gilman-Sachs, and K. D. Beaman, “Regeneration and tolerance factor's potential role in T-cell activation and apoptosis,” Human Immunology, vol. 61, no. 10, pp. 959–971, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. J. S. Boomer, R. A. Derks, G. W. Lee, B. K. DuChateau, A. Gilman-Sachs, and K. D. Beaman, “Regeneration and tolerance factor is expressed during T-lymphocyte activation and plays a role in apoptosis,” Human Immunology, vol. 62, no. 6, pp. 577–588, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Fournel, M. Aguerre-Girr, X. Huc et al., “Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8,” Journal of Immunology, vol. 164, no. 12, pp. 6100–6104, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. J. S. Hunt and D. L. Langat, “HLA-G: a human pregnancy-related immunomodulator,” Current Opinion in Pharmacology, vol. 9, no. 4, pp. 462–469, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. M. S. Vacchio and R. J. Hodes, “Fetal expression of fas ligand is necessary and sufficient for induction of CD8 T cell tolerance to the fetal antigen H-Y during pregnancy,” The Journal of Immunology, vol. 174, no. 8, pp. 4657–4661, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. K. D. Priddy, “Immunologic adaptations during pregnancy,” Journal of Obstetric, Gynecologic, and Neonatal Nursing, vol. 26, no. 4, pp. 388–394, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. A. P. Weetman, “The immunology of pregnancy,” Thyroid, vol. 9, no. 7, pp. 643–646, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Shinoda, M. Watanabe, Y. Nakamura, H. Maruoka, Y. Kimura, and Y. Iwatani, “Physiological changes of Fas expression in peripheral lymphocyte subsets during the menstrual cycle,” Journal of Reproductive Immunology, vol. 60, no. 2, pp. 159–168, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Reinhard, A. Noll, H. Schlebusch, P. Mallmann, and A. V. Ruecker, “Shifts in the TH1/TH2 balance during human pregnancy correlate with apoptotic changes,” Biochemical and Biophysical Research Communications, vol. 245, no. 3, pp. 933–938, 1998. View at Publisher · View at Google Scholar · View at Scopus
  31. S. V. Shirshev, E. M. Kuklina, and A. A. Yarilin, “Role of reproductive hormones in control of apoptosis of T-lymphocytes,” Biochemistry, vol. 68, no. 4, pp. 470–475, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Hofmann-Lehmann, E. Holznagel, and H. Lutz, “Female cats have lower rates of apoptosis in peripheral blood lymphocytes than male cats: correlation with estradiol-17β, but not with progesterone blood levels,” Veterinary Immunology and Immunopathology, vol. 65, no. 2–4, pp. 151–160, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Scudeletti, L. Lanza, E. Monaco et al., “Immune regulatory properties of corticosteroids: prednisone induces apoptosis of human T lymphocytes following the CD3 down-regulation,” Annals of the New York Academy of Sciences, vol. 876, pp. 164–179, 1999. View at Publisher · View at Google Scholar · View at Scopus